Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The obesity epidemic is growing worldwide and in the UK this is perpetuated with a third of women classified as overweight/obese in 2020. Many of these woman are of childbearing age and go on to have high risk pregnancies which are often complicated by gestational or pre-existing (type 2 diabetes mellitus (GDM, T2DM). Bariatric surgery is the most successful treatment of sustainable weight loss and is associated with a reduction in rates of GDM, pre-eclampsia, delivery of large babies but increased risk of delivery of small babies and preterm delivery.
The aims of the study are to investigate the maternal and fetal/neonatal, biophysical and biochemical, intra-uterine environment and postnatal profile of pregnancies:
This is an observational study. The investigators are planning to study pregnant women with normal BMI or overweight (BMI<30), obesity (BMI ≥30) and glucose disorders (GDM and T2DM). The investigators will also study pregnant women with previous bariatric surgery (gastric band, sleeve gastrectomy or gastric bypass) and compare them with pregnant women of similar pre-surgery and early pregnancy BMI, but no hisotry of weight loss surgery.
For all the participants and serially during pregnancy (at 12-14, 20-24, 26-28, 30-32, 35-37 weeks gestation and postnatally (at 6 weeks, 3 months, 12-24 months and 3-7 years of age), the investigators will perform the following investigations:
Maternal investigations: Demographics and medical history will be recorded, weight, height, waist to hip ratio and blood pressure will be measured, blood, urine, stool samples and vaginal swabs will be obtained, cervical length (by trans-vaginal ultrasound) will be measured and maternal echocardiography will be performed. Maternal glucose homeostasis will be assessed at 26-28 weeks of gestation, by a full oral glucose tolerance test, HOMA, home glucose monitoring and/ or continuous glucose monitoring (CGM), depending on the group the women belong to.
Fetal investigations: Fetal growth and well being will be assessed by 2D, 3D and Doppler ultrasound, fetal echocardiography will be performed.
At and following delivery: Maternal blood and urine samples and subcutaneous and omental fat (if Caesarean section is performed) will be obtained, placental tissue will be stored. Neonatal cord blood will be obtained, birthweight (percentiles), anthropometric characteristics will be measured, meconium and urine samples will be obtained and neonatal MRI (to assess body fat distribution) will be arranged.
Postnatal follow up visits for the mother and the infant (at 6 weeks, 3 months, 12-24 months, 3-7 years old) will be arranged and maternal and infant blood and urine samples will be requested and obtained.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pregnant women with obesity/GDM/T2DM | Pregnant women with obesity/GDM/T2DM | ||
| Pregnant women with obesity/GDM/T2DM- Controls | Pregnant women with normal BMI/ no GDM orT2DM | ||
| Post-bariatric pregnant women | Pregnant women with previous bariatric surgery |
| |
| Pregnant no bariatric women- Controls | There will be two control groups of women with no previous bariatric surgery: 1. Pregnant women with booking BMI similar to the booking BMI of the post-bariatric ones and 2. Pregnant women with booking BMI similar to the pre-surgery BMI of the post-bariatric ones. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Observational | Other | This is an observational study |
|
| Measure | Description | Time Frame |
|---|---|---|
| Birth weight (in percentiles) | Birthweight percentiles will be compared in the groups studied | At the time of birth |
| Measure | Description | Time Frame |
|---|---|---|
| Reported pregnancy complications | Compare the percentage of women that develop pre-eclampsia or other complications in the groups studied | During pregnancy and up until the birth of the baby |
| Reported labour outcomes |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Female and pregnant. Only looking at singleton pregnancies.
Pregnant women with a singleton pregnancy that resulted in the delivery of a live, phenotypically normal neonate.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| DAMON FOSTER | Contact | damon.foster2@nhs.net | ||
| DORIS DABY | Contact | doris.daby1@nhs.net |
| Name | Affiliation | Role |
|---|---|---|
| MAKRINA SAVVIDOU, MD | CHELSEA & WESTMINSTER HOSPITAL NHS FT | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chelsea & Westminster Hospital Nhs Ft | Recruiting | London | United Kingdom |
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| D011254 | Pregnancy in Diabetics |
| D011248 | Pregnancy Complications |
| D001724 | Birth Weight |
| D018149 | Glucose Intolerance |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D057832 | Watchful Waiting |
| ID | Term |
|---|---|
| D017063 | Outcome Assessment, Health Care |
| D010043 | Outcome and Process Assessment, Health Care |
| D011787 | Quality of Health Care |
| D006298 | Health Services Administration |
Not provided
Not provided
Not provided
Not provided
Not provided
Maternal blood, urine, stool samples and vaginal swabs.
Neonatal cord blood, urine and meconium samples.
Maternal (after the delivery) and infant blood, urine and stool samples.
The percentage of women who deliver by instrumental deliveries or Caesarean section, in the groups studied
| At birth |
| Maternal and infant weight (in kg) and height (in cm) | Weight and height will be combined to report BMI in kg/m^2, in the groups of women studied | Following the birth: 6 weeks, 3 months, 12-24 months and 3-7 years |
| Maternal and infant blood pressure (in mmHg) | Compare the maternal and infant biophysical profile in the groups of women studied | Following the birth: 6 weeks, 3 months, 12-24 months and 3-7 years |
| Maternal and infant blood and urine samples | Compare the maternal and infant metabolic profile in the groups of women studied | Following the birth: 6 weeks, 3 months, 12-24 months and 3-7 years |
| D001835 |
| Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D006943 | Hyperglycemia |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |